National Organization for Rare Disorders To Partner With Discovery Health and 'MYSTERY DIAGNOSIS' for Rare Diseas... (e Entertainment. For Discovery Health A...)

HOME >> MEDICINE >> NEWS

National Organization for Rare Disorders To Partner With Discovery Health and 'MYSTERY DIAGNOSIS' for Rare Disease Day 2009

Date:2/9/2009

e Entertainment. For Discovery Health, Alon Orstein is executive producer and for True Entertainment, Steven Weinstock, Glenda Hersh and Stephanya J. Miller are executive producers.

About Discovery Health:

Discovery Health Media includes the Discovery Health and FitTV television networks and online assets including www.discoveryhealth.com, as well as its Continuing Medical Education (CME) business and Discovery's first stand-alone VOD service, Discovery Health On-Call. Discovery Health Media is part of Discovery Communications (Nasdaq: DISAD, DISBD, DISCK), the world's number one nonfiction media company reaching more than 1.5 billion cumulative subscribers in over 170 countries. Discovery empowers people to explore their world and satisfy their curiosity through 100-plus worldwide networks, led by Discovery Channel, TLC, Animal Planet, Science Channel, Planet Green, Investigation Discovery and HD Theater, as well as leading consumer and educational products and services, and a diversified portfolio of digital media services including HowStuffWorks.com. For more information, please visit www.discoverycommunications.com.

SOURCE Discovery Health
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. International study strengthens case for daily calcium pill
2. Yakima Health Care Leader Tapped for Leadership Post at National Association
3. Virginia Tech Report Has National Importance
4. Donate Life America Dispels Myths About Organ & Tissue Donation Among Hispanics During National Hispanic Heritage Month
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
8. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
9. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
10. LCA Hails International Investigators Studying Lung Cancer
11. National Patient Safety Foundation Partners with Vocera Communications

Post Your Comments:

(Date:11/9/2009)...v. 9 Sutter Health, a family of do...are service providers, is donating $255,000 to foo...ocal food banks will share the quarter-million-dol...tables of thousands of families across the north s...partnering with and supporting charitable programs...

(Date:11/9/2009)...s with drugs that inhibit estrogen, , ,... to treat breast cancer and osteoporosis eliminate...y. , The drugs also cleared precancerous growth...t of cancer in mice with precancerous lesions. ,...t cancer/osteoporosis drug raloxifene were given t...

(Date:11/9/2009)... both eye conditions are age-related, researchers ...-- Cataract surgery doesn,t appear to speed the pr...), according to a new study that challenges the be...s the other. , "Because both conditions are str...also have AMD," wrote Li Ming Dong, of Stony Brook...

(Date:11/9/2009)...9 /PRNewswire-FirstCall/ - Hard To Treat Diseases ...hat Novartis, a US$41 billion international health...1N1 Vaccine partner, Zhejiang Tianyuan Bio-Pharmac... Switzerland will begin a five-year, $1 billion Ch...matically increase its investment in its China R&a...

(Date:11/9/2009)...sive Cancer Network (NCCN) has posted a draft whit...radigm for near-term comparative effectiveness cli...cument introduces the NCCN Comparative Therapeutic...ompares the risk-versus-benefit of different treat...tice Guidelines in Oncology(TM). The paper will be...

Breaking Medicine News(10 mins):Health News:Sutter Health Donates $255,000 to Help the Hungry This Holiday Season 2 Health News:Breast Cancer Drugs May Fight Cervical Cancer, Too 2 Health News:Cataract Surgery Doesn't Worsen Macular Degeneration: Study 2 Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2 Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3 Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4 Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 2 Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 3 Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 4

[0] Sutter Health Donates $255,000 to Help the Hungry This Holiday Season [0] Breast Cancer Drugs May Fight Cervical Cancer, Too [0] Cataract Surgery Doesn't Worsen Macular Degeneration: Study [2] Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million [0] NCCN Posts Comparative Effectiveness White Paper for Public Comment

...hiladelphia, PA, June 25, 2007 State policies hav...y substance abuse treatment programs, and could pl...arch-based "comprehensive" treatment approaches, r...licy proscriptions emanating from scientific resea...

...tem cell research and the potential use of human e...oversial issue which splits both scientific and pu...stem cells throughout the world deals particularly...t. It is a symbolic struggle over the whole future...

...y dose of rivaroxaban cut risk of venous thromboem... (HealthDay News) -- Extended use of the oral drug... clots after hip replacement surgery, British res.... Current guidelines recommend patients receive a ...

...ARBOR, Mich., June 25 HealthMedia(R), Inc.,s,Succ...o-year Health,Information Products (HIP) Certifica...ance (NCQA), the most trusted source for informati...A, since responsibility for adherence to NCQA HRA ...

...cal Division Officer says " ... when we used Jelly...patients from the painful burning and stinging ...act.", SAVANNAH, Ga., June 25 Captain Kevin Carv...at provided,any true relief until he tried Jellyfi...

...R KNOLLS, N.J., June 25 MedeFile,International, I...zing in,portable electronic medical records manage...usive, membership only, resort community located i...ting of over 1,400 members., Members who subscrib...

Other Medicine News:Health News:State policies influence drug treatment programs 2 Health News:Stem cell research from an ethical point of view 2 Health News:Oral Drug Helps Prevent Clotting After Hip Replacement 2 Health News:HealthMedia Health Risk Assessment Earns Prestigious NCQA Certification 2 Health News:Okaloosa Island Fire Department Will Use Jellyfish Squish to Treat Jellyfish Stings 2 Health News:Okaloosa Island Fire Department Will Use Jellyfish Squish to Treat Jellyfish Stings 3 Health News:Exclusive Resort Community Looks to MedeFile to Provide Members With Access to Medical Records Anytime, Anywhere 2

State policies influence drug treatment programs Stem cell research from an ethical point of view Oral Drug Helps Prevent Clotting After Hip Replacement HealthMedia Health Risk Assessment Earns Prestigious NCQA Certification Okaloosa Island Fire Department Will Use Jellyfish Squish to Treat Jellyfish Stings Exclusive Resort Community Looks to MedeFile to Provide Members With Access to Medical Records Anytime, Anywhere

(Date:11/9/2009)...RMINGHAM, Ala., Nov. 9 S...at it will host an investor conference call at 11:... to discuss its 2009 third quarter operating resul...ly an hour following the conclusion of the confere...gi-bin/prnh/20080812/CLTU111LOGO ) ,, Please...

(Date:11/9/2009)...DFORD, Mass., Nov. 9 Hol... ), a leading developer, manufacturer and supplier...nd surgical products dedicated to serving the heal... for the fourth quarter and fiscal year ended Sept...ed the Board of Directors has promoted Robert Casc...

(Date:11/9/2009)...ENWOOD, Ill., Nov. 9 La...n personal and environmental radiation monitoring ...quisitions in accordance with its long-term strate...the acquisitions of Global Physics Solutions, Inc....ll Saxelby, President and CEO of Landauer. "These ...

[0] Surgical Care Affiliates Announces Investor Conference Call to Discuss 2009 Third Quarter Results [0] Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results [0] Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market

...7 /PRNewswire/ -- Expression,Genetics, Inc., annou...udy evaluating the Company,s lead drug candidate,...f Alabama at,Birmingham and , evaluated the safety...activity of the EGEN-001 in 13 patients,with advan...ct,utilizing the Company,s proprietary TheraPlas(...

...fect on QTc Interval, HAYWARD, Calif., April 16, 2... today presented safety data from,preclinical and ...spimycin (KOS-953). Serial electrocardiogram (ECG)...e 1 trials of tanespimycin.,Cardiac monitoring ana...espimycin was found to have no effect on QTc inter...

Other Medicine Technology:Expression Genetics, Inc. Announces Successful Completion of Phase,I Trial of Gene-Based IL-12 for Treatment of Ovarian Cancer 2 Expression Genetics, Inc. Announces Successful Completion of Phase,I Trial of Gene-Based IL-12 for Treatment of Ovarian Cancer 3 Expression Genetics, Inc. Announces Successful Completion of Phase,I Trial of Gene-Based IL-12 for Treatment of Ovarian Cancer 4 Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor,Tanespimycin (KOS-953) at AACR 2 Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor,Tanespimycin (KOS-953) at AACR 3 Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor,Tanespimycin (KOS-953) at AACR 4

Expression Genetics, Inc. Announces Successful Completion of Phase,I Trial of Gene-Based IL-12 for Treatment of Ovarian Cancer Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor,Tanespimycin (KOS-953) at AACR

Vitreoretinal Viscodissector 45 degrees

Infusion Cannula 6mm

Lacrimal Intubation Tubing

Replacment Tubing

Medicine Products:

Vitreoretinal Viscodissector 45 degrees Infusion Cannula 6mm Lacrimal Intubation Tubing Replacment Tubing

National Organization for Rare Disorders To Partner With Discovery Health and 'MYSTERY DIAGNOSIS' for Rare Diseas...(e Entertainment. For Discovery Health A...),Health